Recent advances in therapeutic strategies for triple-negative breast cancer

Y Li, H Zhang, Y Merkher, L Chen, N Liu… - Journal of hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC)
with a poor prognosis. Current treatment options are limited to surgery, adjuvant …

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

JJ Qin, L Yan, J Zhang, WD Zhang - Journal of Experimental & Clinical …, 2019 - Springer
Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen
receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 …

Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution

U Bharadwaj, MM Kasembeli, P Robinson… - Pharmacological …, 2020 - Elsevier
Before it was molecularly cloned in 1994, acute-phase response factor or signal transducer
and activator of transcription (STAT) 3 was the focus of intense research into understanding …

IL-6/STAT3 is a promising therapeutic target for hepatocellular carcinoma

J Xu, H Lin, G Wu, M Zhu, M Li - Frontiers in oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common malignant tumor of which the occurrence and
development, the tumorigenicity of HCC is involving in multistep and multifactor interactions …

μMap photoproximity labeling enables small molecule binding site mapping

SW Huth, JV Oakley, CP Seath, JB Geri… - Journal of the …, 2023 - ACS Publications
The characterization of ligand binding modes is a crucial step in the drug discovery process
and is especially important in campaigns arising from phenotypic screening, where the …

STAT3 pathway in cancers: Past, present, and future

HQ Wang, QW Man, FY Huo, X Gao, H Lin, SR Li… - MedComm, 2022 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3), a member of the STAT family,
discovered in the cytoplasm of almost all types of mammalian cells, plays a significant role in …

[HTML][HTML] STAT3: A key regulator in liver fibrosis

J Zhao, YF Qi, YR Yu - Annals of Hepatology, 2021 - Elsevier
Janus protein tyrosine kinase (JAK) has the ability to activate signal transducer and activator
of transcription (STAT). STAT3 is a valued member of the JAK/STAT signaling pathway. In …

Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment

MM Kasembeli, U Bharadwaj, P Robinson… - International journal of …, 2018 - mdpi.com
Signal transducer and activator of transcription (STAT) 3 plays a central role in the host
response to injury. It is activated rapidly within cells by many cytokines, most notably those in …

[HTML][HTML] Therapeutic targeting of STAT3 employing small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis

M Tang, Y Chen, B Li, H Sugimoto, S Yang… - … : official publication of …, 2021 - ncbi.nlm.nih.gov
Hepatic fibrosis is a wound healing response that results in excessive extracellular matrix
(ECM) accumulation in response to chronic hepatic injury. Signal transducer and activator of …

[HTML][HTML] Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease

J Jiao, JI Sanchez, OA Saldarriaga, LM Solis… - JHEP Reports, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) and its
severe form, non-alcoholic steatohepatitis (NASH), is increasing. Individuals with NASH …